title: Modulation of male song by naloxone in the medial preoptic nucleus.
abstract: Studies in songbirds implicate opioid neuropeptides in singing behavior; however, past results are contradictory. In starlings, the effect of opioid manipulations on sexually motivated courtship song differed in birds naturally singing at low compared to high rates, and mu-opioid receptors were denser in several regions, including the medial preoptic nucleus (POM) in low singing males. In the present study, we found that low singing male starlings also had significantly higher enkephalin (ENK) immunolabeling densities in the POM than high singers. We blocked opioid receptor activity in the POM with naloxone injections and found that this increased both song rate and song bout length in low singers, suggesting that high densities of mu receptors and ENK in the POM actively suppress song in these males. In contrast to its effects on low singers, naloxone in the POM of high singers dose dependently decreased song rate and tended to reduce song bout length. This suggests that at least some level of opioid activity in POM is necessary for song production. Our results are the first to demonstrate that direct administration of naloxone into the POM influences sexually motivated song, and that effects differ depending on an individual's initial rate of song and associated density of ENK. We suggest that differential effects seen in past studies of opioids and song may in part be explained by differences in the natural song rate of subjects and accompanying differences in ENK activity and neural substrate sensitivity to opioids in POM.
authors.affiliation: Department of Zoology, University of Wisconsin-Madison, Madison, WI 53706, USA. cakelm@wisc.edu
authors.forename: Cynthia A
authors.initials: CA
authors.lastname: Kelm-Nelson
authors.forename: Sharon A
authors.initials: SA
authors.lastname: Stevenson
authors.forename: Melissa A
authors.initials: MA
authors.lastname: Cordes
authors.forename: Lauren V
authors.initials: LV
authors.lastname: Riters
mesh_terms: D000704:Analysis of Variance; D000728:Androgens / Q000008:administration & dosage; D000818:Animals; D004745:Enkephalins / Q000378:metabolism; D005260:Female; D008297:Male; D009270:Naloxone / Q000494:pharmacology*; D009292:Narcotic Antagonists / Q000494:pharmacology*; D017440:Photoperiod; D011301:Preoptic Area / Q000187:drug effects* / Q000378:metabolism; D012726:Sexual Behavior, Animal / Q000187:drug effects / Q000502:physiology*; D046749:Starlings; D013739:Testosterone / Q000008:administration & dosage; D014828:Vocalization, Animal / Q000187:drug effects*
chemical_list: D000728:Androgens; D004745:Enkephalins; D009292:Narcotic Antagonists; D009270:Naloxone; D013739:Testosterone
references.citation: J Chem Neuroanat. 2010 Oct;40(2):123-9
references.pmid: 20471470
references.citation: Eur J Neurosci. 2009 Mar;29(5):970-82
references.pmid: 19245371
references.citation: Front Neuroendocrinol. 2012 Apr;33(2):194-209
references.pmid: 22569510
references.citation: J Biol Rhythms. 2001 Aug;16(4):365-80
references.pmid: 11506381
references.citation: J Chem Neuroanat. 2012 Mar;43(2):87-95
references.pmid: 22198223
references.citation: Eur J Pharmacol. 1997 Apr 18;324(2-3):141-5
references.pmid: 9145764
references.citation: Brain Res. 1995 Nov 13;699(1):83-96
references.pmid: 8616616
references.citation: Behav Neurosci. 2005 Feb;119(1):245-55
references.pmid: 15727529
references.citation: Behav Brain Res. 2010 Apr 2;208(2):359-70
references.pmid: 20015456
references.citation: Horm Behav. 1999 Dec;36(3):276-86
references.pmid: 10603291
references.citation: Proc Natl Acad Sci U S A. 2006 Oct 10;103(41):15212-7
references.pmid: 17018643
references.citation: Physiol Behav. 2006 Jul 30;88(4-5):575-84
references.pmid: 16784760
references.citation: Neurosci Biobehav Rev. 1980 Winter;4(4):473-87
references.pmid: 6258111
references.citation: Pharmacol Rev. 1999 Jun;51(2):341-96
references.pmid: 10353987
references.citation: Behav Neurosci. 1998 Aug;112(4):1001-11
references.pmid: 9733206
references.citation: Behav Neurosci. 1996 Apr;110(2):324-30
references.pmid: 8731059
references.citation: J Pharmacol Exp Ther. 1986 Sep;238(3):924-31
references.pmid: 3746670
references.citation: Eur J Pharmacol. 2000 Sep 29;405(1-3):89-101
references.pmid: 11033317
references.citation: J Chem Neuroanat. 2010 Mar;39(2):141-50
references.pmid: 19995531
references.citation: Life Sci. 1978 Feb;22(7):619-23
references.pmid: 415198
references.citation: J Exp Zool. 1997 Feb 1;277(2):146-54
references.pmid: 9057316
references.citation: Behav Neurosci. 2006 Dec;120(6):1326-36
references.pmid: 17201478
references.citation: Behav Neurosci. 1995 Feb;109(1):123-34
references.pmid: 7734068
references.citation: Behav Brain Res. 2011 May 16;219(1):15-22
references.pmid: 21147175